Positive autoantibodies in living liver donors

Table 1 Demographics and characteristics of living donor liver transplant recipients

		Recipients of transplants from autoantibody positive donors (n = 37), No. (%)	Recipients of transplants from autoantibody negative donors (n = 78), No. (%)	P value
Race/Ethnicity				0.61
	Caucasian	33 (89)	70 (90)
	Hispanic	3 (8)	3 (4)
	Black	0 (0)	4 (5)
	Asian	1 (3)	1 (1)
Gender				0.23
	Male	15 (41)	39 (50)
	Female	22 (59)	39 (50)
Cause for transplantation				0.11
	Alcoholic cirrhosis	6 (16)	8 (10)
	Non-alcoholic steatohepatitis	16 (43)	19 (24)
	Hepatitis B	0 (0)	1 (1)
	Hepatitis C	4 (11)	4 (5)
	PSC	8 (22)	13 (17)
	PBC	1 (3)	3 (4)
	AIH	1 (3)	5 (6)
	With PBC	0	1
	With PSC	1	2
	AIH only	0	2
	Malignancy	0 (0)	7 (9)
	Other1	1 (3)	17 (22)
Age at transplantation		55 ± 15	50 ± 14	0.13
Average BMI		28 ± 6	27 ± 6	0.22
Average MELD at transplantation		15 ± 5	14 ± 5	0.71

¹Other includes biliary atresia 2 (2%), congenital hepatic fibrosis 2 (2%), cryptogenic 6 (5%), common variable immunodeficiency 1 (1%), cystic fibrosis 1 (1%), polycystic liver disease 2 (2%), sarcoidosis 1 (1%), telomere syndrome 1 (1%), and portal vein thrombosis 1 (1%). AIH: Autoimmune hepatitis; BMI: Body mass index; MELD: Model for end-stage liver disease; PBC: Primary biliary cholangitis; PSC: Primary sclerosing cholangitis.